Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...

Neuralink, Elon Musk’s brain-computer venture, and rivals like Max Hodak’s Science, are chasing advances in technology that ...

The boundary between science fiction and medical reality blurs as companies like Elon Musk's Neuralink make strides in ...

Investors are responding to Tesla CEO Elon Musk's close association with President-elect Donald Trump, anticipating a ...

QIAGEN's QIAstat-Dx Meningitis/Encephalitis Panel has received FDA clearance, enabling faster and more accurate diagnosis of ...

Shortly after 2 a.m. on a Saturday in a midtown Manhattan sports bar packed with Aussies, Dr. Tom Oxley was feeling stunned.

Recently, the United States Food and Drug Administration (FDA) issued a draft guidance, Integrating Randomized Controlled Trials for Drug and Biological Products Into Routine Clinical Practice ...

Zelira Therapeutics (AU:ZLD) has released an update. Zelira Therapeutics has made significant strides in its HOPE® program, receiving positive feedback from the FDA to advance towards IND ...

The development of implants that potentially relieve neck and back pain has just been given top priority by Elon Musk’s brain-implant startup, Neuralink ... significant clinical trials, which could ...

Research studies explore the different factors that affect health and lead to disease. Clinical trials test the safety and effectiveness of new cancer drugs and treatments. They help us find better ...

Pfizer Inc. has won regulatory approval for its hympavzi drug as a treatment for hemophilia A or B without inhibitors — making it the first antitissue-factor pathway inhibitor to be allowed for ...

Science Corporation's retinal implant allowed some people who lost their central vision to read, play cards, and recognize faces.